These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30191947)

  • 1. Expression of glutamine metabolism-related proteins in Hürthle cell neoplasm of thyroid: Comparison with follicular neoplasm.
    Cha YJ; Jang H; Koo JS
    Histol Histopathol; 2019 Feb; 34(2):167-174. PubMed ID: 30191947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glutamine metabolism-related proteins in thyroid cancer.
    Kim HM; Lee YK; Koo JS
    Oncotarget; 2016 Aug; 7(33):53628-53641. PubMed ID: 27447554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of Glycolysis-Related Proteins in Follicular Neoplasms versus Hürthle Cell Neoplasms: A Retrospective Analysis.
    Kim HM; Koo JS
    Dis Markers; 2017; 2017():6230294. PubMed ID: 28790533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Autophagy-Related Proteins in Hürthle Cell Neoplasm Is Different from That in Follicular Neoplasm.
    Cha YJ; Kim HM; Koo JS
    Dis Markers; 2017; 2017():1372387. PubMed ID: 28819333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of serine and glycine metabolism-related proteins between follicular neoplasm and Hürthle cell neoplasm.
    Kim HM; Kim ES; Koo JS
    Int J Clin Exp Pathol; 2018; 11(4):2064-2071. PubMed ID: 31938313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer.
    Kim S; Kim DH; Jung WH; Koo JS
    Endocr Relat Cancer; 2013 Jun; 20(3):339-48. PubMed ID: 23507704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.
    Kim S; Jung WH; Koo JS
    Tumour Biol; 2013 Oct; 34(5):2683-9. PubMed ID: 23636801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
    Du K; Chitneni SK; Suzuki A; Wang Y; Henao R; Hyun J; Premont RT; Naggie S; Moylan CA; Bashir MR; Abdelmalek MF; Diehl AM
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):1-21. PubMed ID: 31881361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
    Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
    Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of fine needle aspiration biopsy with and without the use of tumor markers in cytologically indeterminate thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Coll Antropol; 2010 Mar; 34(1):53-7. PubMed ID: 20432733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
    Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
    J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET characteristics of Hürthle cell and follicular adenomas.
    Pathak KA; Klonisch T; Nason RW; Leslie WD
    Ann Nucl Med; 2016 Aug; 30(7):506-9. PubMed ID: 27221817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of Hurthle cell neoplasms by gene profiling.
    Finley DJ; Zhu B; Fahey TJ
    Surgery; 2004 Dec; 136(6):1160-8. PubMed ID: 15657571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
    Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
    Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and ultrasound features of cytology diagnosed follicular neoplasm.
    Choi YJ; Yun JS; Kim DH
    Endocr J; 2009; 56(3):383-9. PubMed ID: 19164864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy.
    McKee S; Wu H; Wang X; Cramer H; Lin J; Chen S
    Acta Cytol; 2014; 58(3):235-8. PubMed ID: 24819535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.